FDA Moving Toward PAT Standardized Nomenclature And Definitions
Executive Summary
FDA is working with the voluntary standards development organization ASTM International to generate standardized nomenclature and consensus definitions of terms associated with process analytical technology
You may also be interested in...
GMP Dispute Resolution Pilot Holds Promise Despite Slow Uptake – FDAer
FDA has received "positive feedback" from industry on its dispute resolution pilot for manufacturing site inspections, but will meet with various trade groups in September to discuss why firms are not participating
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials